Please use this identifier to cite or link to this item:
https://hdl.handle.net/11055/577
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Deer TR | en_US |
dc.contributor.author | Skaribas I | en_US |
dc.contributor.author | McJunkin T | en_US |
dc.contributor.author | Nelson C | en_US |
dc.contributor.author | Salmon J | en_US |
dc.contributor.author | Darnule A | en_US |
dc.contributor.author | Braswell JJ | en_US |
dc.contributor.author | Russo M | en_US |
dc.contributor.author | Gomezese OF | en_US |
dc.date | 2016-02-18 | - |
dc.date.accessioned | 2018-06-15T01:15:21Z | - |
dc.date.available | 2018-06-15T01:15:21Z | - |
dc.date.issued | 2016-02-18 | - |
dc.identifier.citation | 19(2):179-187 | en_US |
dc.identifier.uri | http://hdl.handle.net/11055/577 | - |
dc.description.abstract | OBJECTIVE: This longitudinal, clinical outcome study was a multicenter, prospective, observational, registry with a 24-month assessment of patients implanted with spinal cord stimulation (SCS) systems for the management of chronic pain of the trunk and/or limbs. METHODS: On informed consent and institutional review board approval, 614 patients from 39 sites were enrolled within 30 days following permanent SCS system implantation. Medication usage, patient-reported pain relief (PRP), categorical ratings of pain relief, pain disability index scores (PDI), quality of life (QoL), and patient satisfaction were assessed at enrollment, 3-, 6-, 12-, 18-, and 24-month postimplant. Device-related adverse events (AEs) were recorded and reported. RESULTS: Across all visits, statistically significant improvements were reported on all outcome measures. Mean PRP was 58.5% (± 26.4) at 3 months, 56.8% (± 29.2) at 6 months, 57.7% (± 28.9) at 12 months, 55.6% (± 29.8) at 18 months, and 56.3% (± 30.3) at 24 months. More than 65% of patients at any visit reported a PRP ≥ 50%. Mean PDI scores reduced from 46.9 points at baseline to 32.7, 31.8, 31.5, 32.1, 32.1 points at 3, 6, 12, 18, and 24 months (p ≤ 0.0001), respectively. Greater than 76% of patients at any visit were satisfied with their therapy. The majority of patients categorized pain relief as excellent or good on a 5-item scale and reported overall QoL as greatly improved or improved on a 5-item scale. An average of 88% of patients stopped, decreased, or did not change dose of narcotics/opioids. The most common AE was diminished or loss of pain relief in 11.4% of enrolled patients. CONCLUSIONS: Most patients experienced substantial pain relief and a significant improvement in all outcome measures. These results further support the safety, efficacy, and sustainability of SCS in clinical practice. | en_US |
dc.subject | Chronic Pain | en_US |
dc.subject | clinical trial | en_US |
dc.subject | registry | en_US |
dc.subject | Spinal Cord Stimulation | en_US |
dc.title | Results From the Partnership for Advancement in Neuromodulation Registry: A 24-Month Follow-Up | en_US |
dc.type | Journal Article | en_US |
dc.type.content | Text | en_US |
dc.identifier.journaltitle | Neuromodulation: Technology at the Neural Interface | en_US |
dc.identifier.doi | 10.1111/ner.12378 | en_US |
dc.description.affiliates | Center for Pain Relief, Charleston, WV, USA | en_US |
dc.description.affiliates | Greater Houston Pain Consultants, U.S. Anesthesia Partners, Houston, TX, USA | en_US |
dc.description.affiliates | Arizona Pain Specialists, Scottsdale, AZ, USA | en_US |
dc.description.affiliates | Bluegrass Pain Consultants, Louisville, KY, USA | en_US |
dc.description.affiliates | PainCare Network, Perth Western, Australia | en_US |
dc.description.affiliates | Spine Team Texas, Southlake, TX, USA | en_US |
dc.description.affiliates | The Spine Diagnostic and Pain Treatment Center, Baton Rouge, LA, USA | en_US |
dc.description.affiliates | Hunter Pain Clinic, Newcastle, NSW, Australia | en_US |
dc.description.affiliates | Fundacion Cardiovascular de Colombia, Bucaramanga Santander, Colombia | en_US |
dc.description.pubmeduri | https://www.ncbi.nlm.nih.gov/pubmed/26890015 | en_US |
dc.type.studyortrial | Prospective Cohort Study | en_US |
dc.ispartof.anzcaresearchfoundation | Yes | en_US |
local.message.claim | 2023-05-02T11:41:30.644+1000|||rp00166|||submit_approve|||dc_contributor_author|||None | * |
dc.type.specialty | Anaesthesia | en_US |
item.fulltext | With Fulltext | - |
item.grantfulltext | reserved | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
Appears in Collections: | Scholarly and Clinical |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Results From the Partnership for Advancement in Neuromodulation Registry (ID 54778).pdf Restricted Access | 430.78 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.